Inofab Health Revenue and Competitors
Estimated Revenue & Valuation
- Inofab Health's estimated annual revenue is currently $420k per year.
- Inofab Health's estimated revenue per employee is $70,000
Employee Data
- Inofab Health has 6 Employees.
- Inofab Health grew their employee count by -33% last year.
Inofab Health's People
Name | Title | Email/Phone |
---|
Inofab Health Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $14.1M | 101 | 5% | N/A | N/A |
#2 | $1.6M | 19 | -71% | N/A | N/A |
#3 | $212.8M | 1063 | 5% | $65M | N/A |
#4 | $6.8M | 54 | 8% | N/A | N/A |
#5 | $12.9M | 92 | 2% | $23.1M | N/A |
#6 | $1M | 12 | N/A | N/A | N/A |
#7 | $106.5M | 599 | -17% | $2.3M | N/A |
#8 | $35.6M | 231 | 6% | N/A | N/A |
#9 | $38.3M | 249 | 5% | N/A | N/A |
#10 | $45M | 299 | -4% | $102.6M | N/A |
What Is Inofab Health?
Inofab Health helps both patients and enthusiasts of respiratory health to better understand, track, and proactively manage their lung health using a powerful digital health platform. Spirohome spirometers guarantee clinical-grade accuracy with every test, and the Spirohome app makes spirometry clear, quick and convenient for all users. Access to daily spirometry by patients with respiratory diseases such as asthma, COPD or cystic fibrosis can significantly improve the management of their diseases. Regular monitoring of lung health parameters can help reveal the effectiveness of treatments, make early detection of disease progression possible and help patients avoid unnecessary hospital visits. Incorporating advanced ultrasonic sensor technology, Spirohome spirometers precisely detect the quality and reliability of spirometry results.
keywords:N/AN/A
Total Funding
6
Number of Employees
$420k
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 6 | -33% | N/A |
#2 | $0.9M | 6 | -33% | N/A |
#3 | $37M | 232 | 52% | N/A |